Integer Holdings Corporation (NYSE:ITGR) Given Consensus Rating of “Hold” by Analysts

Shares of Integer Holdings Corporation (NYSE:ITGR) have received a consensus rating of “Hold” from the fourteen ratings firms that are presently covering the firm, MarketBeat.com reports. Thirteen research analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average 1 year price objective among brokers that have issued ratings on the stock in the last year is $109.8571.

A number of brokerages recently weighed in on ITGR. Zacks Research raised shares of Integer from a “strong sell” rating to a “hold” rating in a research note on Monday, July 20th. Piper Sandler downgraded Integer from an “overweight” rating to a “hold” rating and set a $127.00 price target on the stock. in a research note on Monday, August 3rd. Oppenheimer lowered Integer from an “outperform” rating to a “market perform” rating in a report on Monday, August 3rd. Wells Fargo & Company boosted their price target on Integer from $84.00 to $127.00 and gave the company an “equal weight” rating in a report on Tuesday, August 4th. Finally, Freedom Capital cut Integer from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 4th.

Integer Stock Performance

Shares of ITGR opened at $126.40 on Friday. The company has a debt-to-equity ratio of 0.75, a quick ratio of 2.41 and a current ratio of 3.73. Integer has a twelve month low of $62.00 and a twelve month high of $126.79. The firm’s 50 day moving average price is $116.93 and its two-hundred day moving average price is $98.47. The firm has a market cap of $4.30 billion, a P/E ratio of 34.54, a PEG ratio of 2.40 and a beta of 0.62.

Integer (NYSE:ITGR) last released its quarterly earnings results on Monday, August 3rd. The medical equipment provider reported $1.60 earnings per share for the quarter, beating the consensus estimate of $1.38 by $0.22. Integer had a net margin of 6.97% and a return on equity of 12.79%. The company had revenue of $464.11 million during the quarter, compared to analysts’ expectations of $451.07 million. During the same quarter in the prior year, the company earned $1.55 earnings per share. The business’s quarterly revenue was down 2.6% compared to the same quarter last year. On average, analysts forecast that Integer will post 6.09 EPS for the current fiscal year.

Insider Activity at Integer

In other news, insider Kirk K. Thor sold 11,767 shares of the firm’s stock in a transaction that occurred on Tuesday, September 15th. The shares were sold at an average price of $126.23, for a total transaction of $1,485,348.41. Following the completion of the transaction, the insider directly owned 7,153 shares of the company’s stock, valued at $902,923.19. This trade represents a 62.19% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Andrew Senn sold 9,408 shares of Integer stock in a transaction that occurred on Tuesday, September 8th. The shares were sold at an average price of $126.30, for a total transaction of $1,188,230.40. Following the completion of the sale, the insider owned 5,405 shares in the company, valued at $682,651.50. This trade represents a 63.51% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 40,948 shares of company stock worth $5,169,920 in the last 90 days. Company insiders own 1.10% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the business. HBK Investments L P acquired a new stake in Integer in the 2nd quarter valued at $14,502,000. Sequoia Financial Advisors LLC lifted its position in Integer by 4.7% during the 2nd quarter. Sequoia Financial Advisors LLC now owns 3,180 shares of the medical equipment provider’s stock worth $297,000 after buying an additional 142 shares in the last quarter. Corient Private Wealth LP boosted its stake in shares of Integer by 10.7% during the 2nd quarter. Corient Private Wealth LP now owns 48,981 shares of the medical equipment provider’s stock worth $4,577,000 after buying an additional 4,742 shares during the last quarter. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new position in shares of Integer during the 2nd quarter worth about $215,000. Finally, Bluefin Capital Management LLC grew its holdings in shares of Integer by 263.6% in the 2nd quarter. Bluefin Capital Management LLC now owns 30,332 shares of the medical equipment provider’s stock valued at $2,835,000 after acquiring an additional 21,990 shares in the last quarter. Institutional investors and hedge funds own 99.29% of the company’s stock.

About Integer

Integer Holdings Corporation, doing business as Integer, is a medical device contract development and manufacturing company. The company partners with medical technology companies to design, develop and manufacture components and finished products used in a range of healthcare applications.

Integer’s medical products include batteries and power sources, implantable components, electrodes, leads, catheters and other products used in cardiovascular, neuromodulation, vascular, orthopedic, diabetes and minimally invasive medical devices.